p53 And related proteins in epithelial ovarian cancer

This publication has 50 references indexed in Scilit:

• p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity
  Journal of Cancer Research and Clinical Oncology, 1997
• p53 nuclear immunoreactivity as a predictor of response and outcome following chemotherapy for metastatic bladder cancer
  Journal of Cancer Research and Clinical Oncology, 1997
• Quantification of p53 in Epithelial Ovarian Cancer
  Gynecologic Oncology, 1997
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Ki67 Antigen Immunostaining (MIB 1 Monoclonal Antibody) in Serous Ovarian Tumors: Index of Proliferative Activity with Prognostic Significance
  Gynecologic Oncology, 1995
• The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
  Nature, 1994
• p21 is a universal inhibitor of cyclin kinases
  Nature, 1993
• Proliferating cell nuclear antigen in epithelial ovarian cancer: Relation to results at second-look laparotomy and survival
  Gynecologic Oncology, 1992
• The p53 tumour suppressor gene
  Nature, 1991
• Steroid receptors and Ki‐67 reactivity in ovarian cancer and in normal ovary: Correlation with dna flow cytometry, biochemical receptor assay, and patient survival
  The Journal of Pathology, 1990